Financials data is unavailable for this security.
View more
Year on year Zimmer Biomet Holdings Inc grew revenues 6.55% from 6.94bn to 7.39bn. In addition the company has reduced the cost of goods sold as a percent of sales, selling, general and administrative expenses as a percent of sales and interest paid as a percent of sales. These improvements contributed to 342.52% net income growth from 231.40m to 1.02bn.
Gross margin | 71.78% |
---|---|
Net profit margin | 13.27% |
Operating margin | 16.45% |
Return on assets | 4.66% |
---|---|
Return on equity | 7.94% |
Return on investment | 5.40% |
More ▼
Cash flow in USDView more
In 2023, Zimmer Biomet Holdings Inc increased its cash reserves by 10.67%, or 40.10m. The company earned 1.58bn from its operations for a Cash Flow Margin of 21.39%. In addition the company used 778.90m on investing activities and also paid 763.50m in financing cash flows.
Cash flow per share | 9.45 |
---|---|
Price/Cash flow per share | 11.03 |
Book value per share | 62.18 |
---|---|
Tangible book value per share | -3.86 |
More ▼
Balance sheet in USDView more
Current ratio | 1.29 |
---|---|
Quick ratio | 0.629 |
Total debt/total equity | 0.458 |
---|---|
Total debt/total capital | 0.314 |
More ▼
Growth rates in USD
SmartText is unavailable
Div yield(5 year avg) | 0.71% |
---|---|
Div growth rate (5 year) | 0.00% |
Payout ratio (TTM) | 19.88% |
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | 99.58 |
More ▼